Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glycogen Storage Disease”

221 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 221 results

Not applicableLooking for participantsNCT06852612
What this trial is testing

Dietary Treatment Strategies and Metabolic Control in Glycogen Storage Disease Type I

Who this might be right for
Glycogen Storage Disease Type I
Insel Gruppe AG, University Hospital Bern 20
Not applicableStudy completedNCT03843606
What this trial is testing

Modified Ketogenic Diet in Patients With McArdle Disease Part A

Who this might be right for
McArdle Disease
Rigshospitalet, Denmark 11
Not applicableUnknownNCT02120235
What this trial is testing

Investigating Lysosomal Storage Diseases in Minority Groups

Who this might be right for
Lysosomal Storage DisordersGaucher DiseaseFabry Disease+2 more
O & O Alpan LLC 20,000
Not applicableActive Not RecruitingNCT04929002
What this trial is testing

Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage Diseases

Who this might be right for
Glycogen Storage DiseaseMcArdle DiseasePompe Disease (Late-onset)
Rigshospitalet, Denmark 50
Testing effectiveness (Phase 2)Looking for participantsNCT06092034
What this trial is testing

A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease

Who this might be right for
Danon Disease
Rocket Pharmaceuticals Inc. 14
Not applicableAvailableNCT03865836
What this trial is testing

Expanded Access for ATB200/AT2221 for the Treatment of Pompe Disease

Who this might be right for
Pompe Disease
Amicus Therapeutics
Not applicableStudy completedNCT04574830
What this trial is testing

Study to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III (GSD III)

Who this might be right for
Glycogen Storage Disease Type III
Ultragenyx Pharmaceutical Inc 18
Not applicableStudy completedNCT02354664
What this trial is testing

Dynamic Respiratory Muscle Function in Late-Onset Pompe Disease

Who this might be right for
Pompe Disease
University of Florida 14
Not applicableLooking for participantsNCT03564561
What this trial is testing

Natural History of Pompe Disease

Who this might be right for
Glycogen Storage Disease Type II, Adult
Assistance Publique - Hôpitaux de Paris 20
Not applicableNot Yet RecruitingNCT05017402
What this trial is testing

Higher Dose of Alglucosidase Alpha for Pompe Disease

Who this might be right for
Glycogen Storage Disease Type II
Taipei Veterans General Hospital, Taiwan 36
Early research (Phase 1)Study completedNCT03041363
What this trial is testing

Treatment Development of Triheptanoin (G1D)

Who this might be right for
EpilepsyGLUT1DS1Glut1 Deficiency Syndrome 1, Autosomal Recessive+4 more
Juan Pascual 12
Post-approval studies (Phase 4)UnknownNCT02525172
What this trial is testing

Immune Modulation Therapy for Pompe Disease

Who this might be right for
Pompe Disease
National Taiwan University Hospital 8
Not applicableLooking for participantsNCT06636383
What this trial is testing

Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program

Who this might be right for
Glycogen Storage Disease Type Ia
Ultragenyx Pharmaceutical Inc 140
Very early researchEnded earlyNCT02357225
What this trial is testing

A Pilot Study of Pyridostigmine in Pompe Disease

Who this might be right for
Pompe Disease
University of Florida 2
Not applicableStudy completedNCT00113035
What this trial is testing

Screening Protocol to Evaluate Acid Alpha-Glucosidase (GAA) Activity and GAA Gene Mutations in Patients With Late Onset Pompe Disease

Who this might be right for
Pompe Disease
Genzyme, a Sanofi Company 60
Not applicableStudy completedNCT02824068
What this trial is testing

Long-term Outcome in Late-onset Pompe Disease Treated Beyond 36 Months (STIG-Pompe-Study)

Who this might be right for
Pompe Disease
LMU Klinikum 112
Not applicableStudy completedNCT04724213
What this trial is testing

Development of an Assessment Tool for Health-related Quality of Life in Children and Adolescents With Pompe Disease

Who this might be right for
Pompe Disease
University Children's Hospital, Zurich 101
Testing effectiveness (Phase 2)UnknownNCT05960617
What this trial is testing

Efficacy and Safety of Empagliflozin in GSD-Ib Patients

Who this might be right for
Glycogen Storage Disease Type IB
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 10
Not applicableStudy completedNCT04694547
What this trial is testing

Ketogenic Diet Survey in Patients With McArdle Disease (GSDV)

Who this might be right for
McArdle Disease
Nicoline Løkken 200
Testing effectiveness (Phase 2)Study completedNCT01942590
What this trial is testing

Safety and Efficacy of Clenbuterol in Individuals With Late-onset Pompe Disease and Receiving Enzyme Replacement Therapy

Who this might be right for
Pompe Disease
Dwight Koeberl, M.D., Ph.D. 17
Load More Results